TY  - JOUR
AU  - Quintero Gutiérrez Del Álamo, Francisco Javier
AU  - Oyagüez, Itziar
AU  - González, Beatriz
AU  - Cuervo-Arango, Ignacio
AU  - García Cabeza, Ignacio
AU  - Casado, Miguel Ángel
PY  - 2015
DO  - 10.1007/s40261-016-0393-z
SN  - 1179-1918
UR  - https://hdl.handle.net/20.500.14352/96937
T2  - Clinical Drug Investigation
AB  - Background and objective: Long-acting formulations for paliperidone (PPLAT) and risperidone (RLAT) are effective second-generation antipsychotics. This study aimed to compare treatment costs between PPLAT and RLAT in schizophrenia patients.Methods: A...
LA  - eng
M2  - 479
PB  - Springer
KW  - Schizophrenia
KW  - Palmitate Paliperidone
KW  - Risperidone
KW  - Cost-Minimisation
TI  - Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
T2  - Análisis de minimización de costes del tratamiento de acción prolongada con palmitato de paliperidona frente al tratamiento de acción prolongada con risperidona para la esquizofrenia en España
TY  - journal article
VL  - 36
ER  -